AR231635A1 - Procedimiento para preparar acidos azabiciclicos - Google Patents

Procedimiento para preparar acidos azabiciclicos

Info

Publication number
AR231635A1
AR231635A1 AR282571A AR28257180A AR231635A1 AR 231635 A1 AR231635 A1 AR 231635A1 AR 282571 A AR282571 A AR 282571A AR 28257180 A AR28257180 A AR 28257180A AR 231635 A1 AR231635 A1 AR 231635A1
Authority
AR
Argentina
Prior art keywords
azabiciclic
acids
preparing
procedure
preparing azabiciclic
Prior art date
Application number
AR282571A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25781063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR231635(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AR231635A1 publication Critical patent/AR231635A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
AR282571A 1979-09-19 1980-09-17 Procedimiento para preparar acidos azabiciclicos AR231635A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792937779 DE2937779A1 (de) 1979-09-19 1979-09-19 Aminosaeurederivate und verfahren zu ihrer herstellung
DE19792946909 DE2946909A1 (de) 1979-09-19 1979-11-21 Neue tetrahydroisochinolinderivate

Publications (1)

Publication Number Publication Date
AR231635A1 true AR231635A1 (es) 1985-01-31

Family

ID=25781063

Family Applications (1)

Application Number Title Priority Date Filing Date
AR282571A AR231635A1 (es) 1979-09-19 1980-09-17 Procedimiento para preparar acidos azabiciclicos

Country Status (10)

Country Link
EP (2) EP0029488A1 (hu)
JP (1) JPS5653655A (hu)
AR (1) AR231635A1 (hu)
AU (1) AU544515B2 (hu)
DE (3) DE2937779A1 (hu)
DK (1) DK395580A (hu)
ES (1) ES494989A0 (hu)
FI (1) FI802918A (hu)
HU (1) HU182203B (hu)
IL (1) IL61058A0 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA80248B (en) * 1979-02-07 1980-12-31 Morton Norwich Products Inc 1-((acylthio) and (mercapto)-1-oxoalkyl)-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
US4303583A (en) * 1979-08-13 1981-12-01 American Home Products Corporation 1H,5H-[1,4]Thiazepino[4,3-a]indole-1,5-diones
US4599357A (en) * 1979-12-17 1986-07-08 Ciba-Geigy Corporation 1-mercaptoalkanoylindoline-2-carboxylic acids
IE52663B1 (en) * 1980-04-02 1988-01-20 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids
US5200416A (en) * 1980-05-12 1993-04-06 Usv Pharmaceutical Corporation Cyclic amides
US4350633A (en) 1980-07-01 1982-09-21 American Home Products Corporation N-(2-Substituted-1-oxoalkyl)-2,3-dihydro-1H-indole-2-carboxylic acid derivatives
US4401818A (en) 1980-12-24 1983-08-30 Ciba-Geigy Corporation 1-Carboxyalkanoyl-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
US4454291A (en) * 1981-07-20 1984-06-12 American Home Products Corporation N-(2-Substituted-1-oxoalkyl)-2,3-dihydro-1H-indole-2-carboxylic acid derivatives
US4454292A (en) * 1981-07-20 1984-06-12 American Home Products Corporation N-[2-Substituted-1-oxoalkyl]-2,3-dihydro-1H-indole-2-carboxylic acid derivatives
JPS5910570A (ja) * 1982-07-08 1984-01-20 Wakamoto Pharmaceut Co Ltd 新規イソカルボスチリル誘導体及びその製法
IT1191109B (it) * 1982-12-03 1988-02-24 Simes Derivati di acidi aminopiridincarbossilici,loro metodo di sintesi e composizioni farmaceutiche che li contengono
DE3303344A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
GB2144994B (en) * 1983-08-09 1987-04-15 Ciba Geigy Compositions for controlling insects, and members of the order acarina, which contain 2-(1-indoliny1-methy1)-imidazolines or salts thereof
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
TW197945B (hu) * 1990-11-27 1993-01-11 Hoechst Ag
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
JPS5572169A (en) * 1978-11-27 1980-05-30 Tanabe Seiyaku Co Ltd Isoquinoline derivative and its preparation
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
EP0018104B1 (en) * 1979-03-26 1983-05-25 Takeda Chemical Industries, Ltd. Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension

Also Published As

Publication number Publication date
FI802918A (fi) 1981-03-20
DE2937779A1 (de) 1981-04-09
IL61058A0 (en) 1980-11-30
EP0029488A1 (de) 1981-06-03
AU6251480A (en) 1981-04-09
DE3072064D1 (en) 1988-02-11
EP0142739B1 (de) 1988-01-07
EP0142739A3 (hu) 1985-07-17
HU182203B (en) 1983-12-28
ES8106705A1 (es) 1981-08-01
JPS5653655A (en) 1981-05-13
ES494989A0 (es) 1981-08-01
DE2946909A1 (de) 1981-06-04
AU544515B2 (en) 1985-06-06
DK395580A (da) 1981-04-02
EP0142739A2 (de) 1985-05-29

Similar Documents

Publication Publication Date Title
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
MX5449E (es) Procedimiento para preparar acidos hidroxidifosfonicos
ES492943A0 (es) Procedimiento para preparar polieteres sililados
ES490764A0 (es) Procedimiento para preparar esteres de acil-carnitinas
ES494352A0 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
AR231635A1 (es) Procedimiento para preparar acidos azabiciclicos
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
MX5604E (es) Procedimiento para preparar aril-hidantoina
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX6816E (es) Procedimiento para preparar quinolonas
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
IT8047797A0 (it) Procedimento per preparare d-alfaamminoacidi
ES495404A0 (es) Procedimiento para preparar esteres
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
MX6141E (es) Procedimiento para preparar acil-ureas
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
MX149268A (es) Procedimiento para preparar acidos diperoxidicarboxilicos alifaticos
ES478787A0 (es) Procedimiento para preparar acidos fenilalcanoicos.
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
ES546650A0 (es) Procedimiento para preparar acidos fenoxialcanoicos
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina